To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Pfizer Investigational Site, New York

Pfizer Investigational Site, New York

Pfizer Investigational Site, The Bronx

Pfizer Investigational Site, Rochester

Pfizer Investigational Site, Philadelphia

Pfizer Investigational Site, Baltimore

Pfizer Investigational Site, Baltimore

Pfizer Investigational Site, Winston-Salem

Pfizer Investigational Site, Miami

Pfizer Investigational Site, Plantation

Pfizer Investigational Site, Nashville

Pfizer Investigational Site, Columbus

Pfizer Investigational Site, Cleveland

Pfizer Investigational Site, Indianapolis

Pfizer Investigational Site, Indianapolis

Pfizer Investigational Site, Bonn

Pfizer Investigational Site, Madison

Pfizer Investigational Site, Madison

Pfizer Investigational Site, Saint Paul

Pfizer Investigational Site, Chesterfield

Pfizer Investigational Site, Little Rock

Pfizer Investigational Site, Los Angeles

Pfizer Investigational Site, Stanford

Pfizer Investigational Site, Boston

Pfizer Investigational Site, Ann Arbor